Syros Pharmaceuticals (SYRS) Earnings
|
Expand Research on SYRS
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -13.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/1/18 |  |
Q318 | -$0.47 | -$0.46 | -$0.01 | $400K | $450K | N/A |  | | Details |
| 8/1/19 | |
Q219 | -$0.47 | -$0.42 | -$0.05 | $462K | $430K | N/A | | | Details |
| 3/7/19 | |
Q418 | -$0.54 | -$0.49 | -$0.05 | $893K | $390K | N/A | | | Details |
| 8/7/18 | |
Q218 | -$0.43 | -$0.50 | +$0.07 | N/A | $800K | N/A | | | Details |
| 8/6/20 | |
Q220 | -$0.38 | -$0.40 | +$0.02 | $3.19M | $1.9M | N/A | | | Details |
| 3/4/21 | |
Q420 | -$0.62 | -$0.50 | -$0.12 | $5.7M | $2.7M | N/A | | | Details |
| 11/14/23 | Q323 | -$1.43 | -$1.14 | -$0.29 | $3.76M | $3.94M | N/A | | | Details | |
| 8/8/23 | Q223 | -$1.30 | -$1.13 | -$0.17 | $2.8M | $3.5M | N/A | | | Details |
